Avoro Capital Advisors — 2021 Investments

2 investments dated 2021 · listed companies and verified rows first · show all

Scribe Therapeuticsscribetx.comin 𝕏NASDAQ: SCTXMar 2021

Scribe is a molecular engineering company developing CRISPR-based genetic therapies to treat cardiometabolic disease and other conditions.

BiotechDeep TechHealthtechMedical DevicesBerkeley, US

Benjamin Oakes(Founder & CEO)Jennifer A. Doudna, PhD(Co-founder, Scientific Advisor)Benjamin L. Oakes, PhD(Co-founder, President and CEO)David F. Savage, PhD(Co-founder, Scientific Advisor)Brett Staahl, PhD(Co-founder, VP of External Innovation)

BoardVijay Pande(Director)

Nuvalent in 𝕏Apr 2021

HealthtechCambridge, US

Matthew Shair(Director)Cameron Wheeler(Director)Gary Gilliland(Director)Robert Jackson(Director)Joseph Pearlberg(Director)R. Porter James(Executive Officer, Director)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.